{"DataElement":{"publicId":"2182728","version":"3","preferredName":"Agent Dose","preferredDefinition":"The amount that represents the dose of the agent.","longName":"AGT_DOSE","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2179571","version":"2.31","preferredName":"Dose Amount","preferredDefinition":"The quantity or dosage of the agent or drug administered to the patient.","longName":"DOSE_AMOUNT","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2177152","version":"1","preferredName":"Dose","preferredDefinition":"The amount of medicine taken, or radiation given, at one time.","longName":"Dose","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A51-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2440114","version":"1","preferredName":"Quantity","preferredDefinition":"Quantity; how much there is of something that you can measure.","longName":"C25256","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Quantity","conceptCode":"C25256","definition":"How much there is of something that you can measure; the total amount or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"08704E62-EF89-4DBA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-25","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-12-25","modifiedBy":"ONEDATA","dateModified":"2005-12-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP:Cancer Therapy Evaluation Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFCBA97B-D1CF-5D7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"02/22/2013 - tc - Replaced Property retired concept C25417 with C25256.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182726","version":"2","preferredName":"Agent Dose","preferredDefinition":"The amount of agent taken at one time.","longName":"AGT_DOSE","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"3","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":"4","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008514","version":"1","preferredName":"DCP Conceptual Domain","preferredDefinition":"DCP Conceptual Domain","longName":"DCP","context":"DCP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A946859C-932E-4C16-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-08-28","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-28","modifiedBy":"MAESKEB","dateModified":"2004-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2432127","version":"1","preferredName":"Dose","preferredDefinition":"The amount of medicine taken, or radiation given, at one time.","longName":"C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"061284D5-1977-0705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-11-21","modifiedBy":"ONEDATA","dateModified":"2005-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"30FFF163-B852-B876-E050-BB89AD434BC7","latestVersionIndicator":"Yes","beginDate":"2004-04-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-04-21","modifiedBy":"KNABLEJ","dateModified":"2017-07-07","changeDescription":"7/7/17 jk transferred context and added registration status, CSI per Round 5 finalization task.  --- Versioned to update the Representation Term to the preferred.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"},{"publicId":"2811734","version":"1","longName":"Case Report Forms","context":"DCP"},{"publicId":"2812325","version":"1","longName":"SeriousAdverseEvents","context":"DCP"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2992453","version":"1","longName":"Candidate Reuse","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"2812342","version":"1","longName":"Proposed","context":"NCIP"},{"publicId":"2812976","version":"1","longName":"LOINC Lab Tests","context":"NCIP"},{"publicId":"3449457","version":"1","longName":"Study Agent Administration","context":"NCIP"},{"publicId":"2867243","version":"1","longName":"Prior/Post Therapies CRF","context":"NCIP"},{"publicId":"2867242","version":"1","longName":"Concomitant Medication CRF","context":"NCIP"},{"publicId":"3028710","version":"1","longName":"Radiation Therapy CRF","context":"NCIP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"2812388","version":"1","longName":"Oral Leukoplakia","context":"DCP"},{"publicId":"2812415","version":"1","longName":"Sulindac for Breast Cancer","context":"DCP"},{"publicId":"2812399","version":"1","longName":"Polyphenon E for Cervical Ca","context":"DCP"},{"publicId":"2812377","version":"1","longName":"Bladder Cancer","context":"DCP"},{"publicId":"2812364","version":"1","longName":"Barretts Esophagus","context":"DCP"},{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812194","version":"1","longName":"ALA PDT - Oral Leukoplakia","context":"DCP"},{"publicId":"2812516","version":"1","longName":"Subclinical Neoplastic Lesions","context":"DCP"},{"publicId":"2812148","version":"1","longName":"SAMe - Hepatitis C cirrhosis","context":"DCP"},{"publicId":"2812149","version":"1","longName":"Pancreatic Mucinous Neoplasms","context":"DCP"},{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"},{"publicId":"2812157","version":"1","longName":"Melanoma Pathobiology - Lovastatin","context":"DCP"},{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812188","version":"1","longName":"Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men","context":"DCP"},{"publicId":"2812202","version":"1","longName":"DIM - Prostate Cancer","context":"DCP"},{"publicId":"2812189","version":"1","longName":"Polyphenon E - Pre-prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"2812539","version":"1","longName":"Polyphenon E - Bladder Cancer","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2812768","version":"1","longName":"PK and Safety - Novel Retinoid (9cUAB30)","context":"DCP"},{"publicId":"2812843","version":"1","longName":"Polyethylene Glycol - Colon Carcinogenesis","context":"DCP"},{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"},{"publicId":"2812949","version":"1","longName":"Exp. PK Formulations of SR13668","context":"DCP"},{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"},{"publicId":"2812735","version":"1","longName":"3, 3-Diindolylmethane Cervical Intraepithelial","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"2813002","version":"1","longName":"Sulindac - Increased Risk of Melanoma","context":"DCP"},{"publicId":"2813043","version":"1","longName":"Ursodeoxycholic Acid - Barrett's Patients","context":"DCP"},{"publicId":"2979172","version":"1","longName":"MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"},{"publicId":"2936518","version":"1","longName":"Polyphenon E in Women w/ Modulation of Arachidonic Acid","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"2964591","version":"1","longName":"Eligibility Criteria","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2965104","version":"1","longName":"Structured Eligibility Criteria","context":"NCIP"},{"publicId":"3070843","version":"1","longName":"Prior Treatment","context":"NCIP"}]},{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]},{"publicId":"3234177","version":"1","longName":"Patient Outcomes Data System (PODS)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3234178","version":"1","longName":"PODS Elements","context":"NCIP"}]},{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461588","version":"1","longName":"General Elements","context":"NCIP"},{"publicId":"3461589","version":"1","longName":"Imaging Elements","context":"NCIP"}]},{"publicId":"3835419","version":"1","longName":"Pharmacovigilance-Gabapentin/Pregabalin","context":"DCI","ClassificationSchemeItems":[{"publicId":"3902524","version":"1","longName":"Follow Up","context":"DCI"},{"publicId":"3835421","version":"1","longName":"Baseline","context":"DCI"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]},{"publicId":"3886753","version":"1","longName":"General Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902138","version":"1","longName":"General","context":"BOLD"}]},{"publicId":"3886754","version":"1","longName":"Imaging Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902139","version":"1","longName":"Imaging","context":"BOLD"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4261112","version":"1","longName":"UAZ2013-02-01","context":"DCP"},{"publicId":"4261412","version":"1","longName":"MDA2013-01-01","context":"DCP"},{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"},{"publicId":"4261411","version":"1","longName":"MAY2013-01-01","context":"DCP"},{"publicId":"3694151","version":"1","longName":"MAY2012-00-01","context":"DCP"},{"publicId":"3896537","version":"1","longName":"UWI2013-01-02","context":"DCP"},{"publicId":"3896538","version":"1","longName":"UAZ2013-01-01","context":"DCP"},{"publicId":"4111771","version":"1","longName":"UWI2013-00-01","context":"DCP"},{"publicId":"4528051","version":"1","longName":"MAY2013-02-02","context":"DCP"},{"publicId":"4528052","version":"1","longName":"MAY2013-02-01","context":"DCP"},{"publicId":"4528053","version":"1","longName":"NWU2014-03-01","context":"DCP"},{"publicId":"4528055","version":"1","longName":"UAZ2014-03-01","context":"DCP"},{"publicId":"4915511","version":"1","longName":"UAZ2015-05-01","context":"DCP"},{"publicId":"4915512","version":"1","longName":"UAZ2015-05-02","context":"DCP"},{"publicId":"5280818","version":"1","longName":"UWI2014-03-01","context":"DCP"},{"publicId":"5416571","version":"1","longName":"MDA2013-02-02","context":"DCP"},{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"},{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"},{"publicId":"5592146","version":"1","longName":"MAY2015-05-01","context":"DCP"},{"publicId":"5612586","version":"1","longName":"MAY2016-07-01","context":"DCP"},{"publicId":"5280812","version":"1","longName":"NWU2015-06-01","context":"DCP"},{"publicId":"5280813","version":"1","longName":"NWU2015-06-02","context":"DCP"},{"publicId":"5981652","version":"1","longName":"UAZ2017-09-02","context":"DCP"},{"publicId":"6005698","version":"1","longName":"MAY2017-09-01","context":"DCP"},{"publicId":"5889185","version":"1","longName":"UWI2016-08-01","context":"DCP"},{"publicId":"5889177","version":"1","longName":"MDA2016-08-02","context":"DCP"},{"publicId":"6046252","version":"1","longName":"UAZ2016-08-02","context":"DCP"},{"publicId":"5280816","version":"1","longName":"UWI2015-05-01","context":"DCP"},{"publicId":"5889178","version":"1","longName":"MDA2017-09-03","context":"DCP"},{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"},{"publicId":"5889187","version":"1","longName":"UWI2017-09-01","context":"DCP"},{"publicId":"5889176","version":"1","longName":"MDA2016-07-02","context":"DCP"},{"publicId":"4528056","version":"1","longName":"NWU2013-02-01","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4104933","version":"1","longName":"RTOG-1308","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"4104901","version":"1","longName":"GOG-0286B","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"}]},{"publicId":"4382692","version":"1","longName":"FDA MedWatch Form 3500","context":"ONC SDC Project","ClassificationSchemeItems":[{"publicId":"4394093","version":"1","longName":"Suspect Product(s)","context":"ONC SDC Project"},{"publicId":"4940571","version":"1","longName":"All Sections","context":"ONC SDC Project"}]},{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736433","version":"1","longName":"Kidney Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736434","version":"1","longName":"Lung Surgery-Anesthesia","context":"BBRB"},{"publicId":"6736435","version":"1","longName":"Ovary Sugery-Anesthesia","context":"BBRB"},{"publicId":"6736432","version":"1","longName":"Colon Surgery-Anesthesia","context":"BBRB"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635322","version":"1","longName":"Prior/Post Therapies","context":"NCI Standards"},{"publicId":"10000582","version":"1","longName":"Study Agent Administration","context":"NCI Standards"},{"publicId":"3028706","version":"1","longName":"Radiation Therapy","context":"NCI Standards"},{"publicId":"5635301","version":"1","longName":"Concomitant Medication","context":"NCI Standards"}]},{"publicId":"5858960","version":"1","longName":"Adopted","context":"NRDS","ClassificationSchemeItems":[{"publicId":"5858965","version":"1","longName":"SAE","context":"NRDS"}]},{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"10000092","version":"1","longName":"RAVE Integrations","context":"NRDS"},{"publicId":"4861352","version":"1","longName":"CDUS","context":"NRDS"}]}],"AlternateNames":[{"name":"NRDS","type":"USED_BY","context":"NRDS"},{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"DRUGTOT","type":"OID, SWOG","context":"SWOG"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"BOLD","type":"USED_BY","context":"BOLD"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"ONC SDC Project","type":"USED_BY","context":"ONC SDC Project"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"BBRB","type":"USED_BY","context":"BBRB"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"AGT_DOSE","type":"USED_BY","context":"CCTG"},{"name":"PR_PRDOSE_RT","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"CRF Text2","type":"Alternate Question Text","description":"Total dose given","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Busulfan dose","url":null,"context":"CTEP"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Total Busulfan administered over 4 days","url":null,"context":"CTEP"},{"name":"Total Dose Delivered","type":"Alternate Question Text","description":"Total Dose Delivered","url":null,"context":"DCI"},{"name":"Infusion Drug Dose (mg)","type":"Alternate Question Text","description":"Infusion Drug Dose (mg)","url":null,"context":"DCI"},{"name":"ECOG CRF 1","type":"Alternate Question Text","description":"Agent total dose","url":null,"context":"ECOG-ACRIN"},{"name":"ECOG CRF Text 1","type":"Alternate Question Text","description":"Total Agent Dose","url":null,"context":"ECOG-ACRIN"},{"name":"OHSU Text 1","type":"Alternate Question Text","description":"A.M. Dose","url":null,"context":"OHSU Knight"},{"name":"OHSU Text 2","type":"Alternate Question Text","description":"P.M. Dose","url":null,"context":"OHSU Knight"},{"name":"ECOG CRF Text 2","type":"Alternate Question Text","description":"Dose administered","url":null,"context":"ECOG-ACRIN"},{"name":"Dose or Amount","type":"Alternate Question Text","description":"Dose or Amount","url":null,"context":"ONC SDC Project"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"What was the total dose of brentuximab vedotin during this reporting period?","url":null,"context":"COG"},{"name":"ECOG CRF Text 3","type":"Alternate Question Text","description":"Total dose","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Total dose of IMGN901 during the reporting period","url":null,"context":"COG"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Total dose administered","url":null,"context":"Alliance"},{"name":"NRG CRF_Text","type":"Alternate Question Text","description":"Dose amount","url":null,"context":"NRG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"Total dose of agent during the reporting period:","url":null,"context":"COG"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Methotrexate Dose","url":null,"context":"Alliance"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"Total dose of Cabozantinib during the reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 7","type":"Alternate Question Text","description":"Total dose of Bleomycin administered during this reporting period:","url":null,"context":"COG"},{"name":"CRF Text5","type":"Alternate Question Text","description":"6MP Dose","url":null,"context":"Alliance"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Total drug given during cycle:","url":null,"context":"COG"},{"name":"NRDS Question Text","type":"Alternate Question Text","description":"Dose/Total dose of the investigational agent administered per course","url":null,"context":"NRDS"},{"name":"NRDS Alternate Text 1","type":"Alternate Question Text","description":"Dose administered (this cycle)","url":null,"context":"NRDS"},{"name":"NRDS Alternate Text 2","type":"Alternate Question Text","description":"Dose administered (this course)","url":null,"context":"NRDS"},{"name":"NRDS Alternate Text 3","type":"Alternate Question Text","description":"Dose administered (this visit)","url":null,"context":"NRDS"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Total/Cumulative Dose Delivered","url":null,"context":"COG"},{"name":"RT TX Form","type":"Alternate Question Text","description":"Radiation therapy total dose received","url":null,"context":"ECOG-ACRIN"},{"name":"CCTG - 3","type":"Alternate Question Text","description":"If DCE was performed, what was the dose of IV gadolinium","url":null,"context":"CCTG"},{"name":"COG CRF Text 12","type":"Alternate Question Text","description":"Total dose of Axitinib administered during this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 13","type":"Alternate Question Text","description":"Total dose of Nivolumab administered during this reporting period:","url":null,"context":"COG"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Total Dose","url":null,"context":"PBTC"},{"name":"Dose","type":"Preferred Question Text","description":"Dose","url":null,"context":"DCP"},{"name":"DCP-text-1","type":"Alternate Question Text","description":"Agent Administration:Dose","url":null,"context":"DCP"},{"name":"CCTG - 1","type":"Alternate Question Text","description":"If yes, dose given","url":null,"context":"CCTG"},{"name":"COG  CRF Text 10","type":"Alternate Question Text","description":"Total dose of veliparib for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Total dose of temozolomide for this reporting period:","url":null,"context":"COG"},{"name":"CCTG - 2","type":"Alternate Question Text","description":"Dose of IV gadolinium for the DSC perfusion series","url":null,"context":"CCTG"},{"name":"COG CRF Text 14","type":"Alternate Question Text","description":"Total dose of dabrafenib for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 15","type":"Alternate Question Text","description":"Total dose of trametinib for this reporting period:","url":null,"context":"COG"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Total Dose","url":null,"context":"Alliance"},{"name":"COG CRF Text 16","type":"Alternate Question Text","description":"Total dose of selinexor for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF TEXT 17","type":"Alternate Question Text","description":"Dose for RP of collection","url":null,"context":"COG"},{"name":"COG CRF Text 18","type":"Alternate Question Text","description":"What was the Busulfan dose used for PK assessment?","url":null,"context":"COG"},{"name":"COG CRF TEXT 19","type":"Alternate Question Text","description":"Total dose given per day","url":null,"context":"COG"},{"name":"DCP-Text-2","type":"Alternate Question Text","description":"Agent Dose","url":null,"context":"DCP"},{"name":"DCP-Text-3","type":"Alternate Question Text","description":"Medication or Treatment Dose","url":null,"context":"DCP"},{"name":"DCP-Text-4","type":"Alternate Question Text","description":"Agent Administration:Dose","url":null,"context":"DCP"},{"name":"COG CRF Text 20","type":"Alternate Question Text","description":"Methotrexate dose mg/m2:","url":null,"context":"COG"},{"name":"COG CRF Text 22","type":"Alternate Question Text","description":"TOTAL dose of vincristine for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 23","type":"Alternate Question Text","description":"TOTAL dose of lomustine for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 24","type":"Alternate Question Text","description":"TOTAL dose of cisplatin for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 25","type":"Alternate Question Text","description":"TOTAL dose of sodium thiosulfate for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 26","type":"Alternate Question Text","description":"TOTAL dose of cyclophosphamide  for this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 21","type":"Alternate Question Text","description":"Total dose of Lorlatinib administered during the reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 27","type":"Activity Diagram","description":"Actual dose given if dose is modified:","url":null,"context":"COG"},{"name":"COG CRF TEXT 28","type":"Alternate Question Text","description":"Actual dose given if dose is modified:","url":null,"context":"COG"},{"name":"CCTG_1","type":"Alternate Question Text","description":"Total dose administered:","url":null,"context":"CCTG"},{"name":"COG CRF Text 29","type":"Alternate Question Text","description":"Dosage:","url":null,"context":"COG"},{"name":"COG CRF Text 30","type":"Alternate Question Text","description":"What was the busulfan dose administered?","url":null,"context":"COG"},{"name":"COG CRF Text 31","type":"Alternate Question Text","description":"Specify Dose:","url":null,"context":"COG"},{"name":"COG CRF Text 32","type":"Alternate Question Text","description":"Asparaginase dose:","url":null,"context":"COG"},{"name":"COG CRF Text 33","type":"Alternate Question Text","description":"Asparaginase Dose delivered (Pegaspargase or calaspargase pegol):","url":null,"context":"COG"},{"name":"Antiviral dose:","type":"Alternate Question Text","description":"Antiviral dose:","url":null,"context":"COG"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"31000384-31E9-D125-E050-BB89AD437303","latestVersionIndicator":"Yes","beginDate":"2016-04-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-04-21","modifiedBy":"KUMMEROA","dateModified":"2023-11-09","changeDescription":"Versioned CDE to use a different VD; versioned CDE to update the Rep Term in the VD.","administrativeNotes":"2023.11.9 AQT added per ticket requestCADSR0003063. ak  added alt name OID, CCTG 5/31/22 cjl 2022.11.18 AQT added for ticket request CADSR0001705. ak 2022.12.1 AQT added for ticket request CADSR0001748. ak","unresolvedIssues":null,"deletedIndicator":"No"}}